Abrdn World Healthcare Fund (NYSE:THW) Short Interest Down 50.8% in August

Abrdn World Healthcare Fund (NYSE:THW) was the target of a significant decrease in short interest during the month of August. As of August 14th, there was short interest totaling 24,996 shares, a decrease of 50.8% from the July 30th total of 50,789 shares. Based on an average daily trading volume, of 112,598 shares, the short-interest ratio is currently 0.2 days.

Institutional Trading of Abrdn World Healthcare Fund

Institutional investors have recently modified their holdings of the company. Allied Private Wealth LLC acquired a new stake in shares of Abrdn World Healthcare Fund during the 2nd quarter worth approximately $27,000. Advisory Services Network LLC bought a new position in Abrdn World Healthcare Fund in the third quarter worth $43,000. B. Riley Wealth Advisors Inc. bought a new stake in Abrdn World Healthcare Fund in the 2nd quarter valued at $113,000. Mercer Global Advisors Inc. ADV bought a new stake in Abrdn World Healthcare Fund in the 4th quarter valued at $157,000. Finally, HighTower Advisors LLC acquired a new position in shares of Abrdn World Healthcare Fund in the 4th quarter valued at $168,000.

Abrdn World Healthcare Fund Stock Down 0.5%

Shares of NYSE THW traded down $0.07 during mid-day trading on Friday, hitting $13.95. The company had a trading volume of 109,289 shares, compared to its average volume of 137,120. Abrdn World Healthcare Fund has a 12 month low of $11.18 and a 12 month high of $14.50. The business’s 50-day simple moving average is $13.54 and its 200-day simple moving average is $12.82.

Abrdn World Healthcare Fund Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Monday, August 31st. Shareholders of record on Monday, August 24th will be issued a $0.1167 dividend. The ex-dividend date of this dividend is Monday, August 24th. This represents a c) annualized dividend and a yield of 10.0%.

Abrdn World Healthcare Fund Company Profile

Abrdn World Healthcare Fund (NYSE: THW) is a closed-end investment company that provides investors with diversified exposure to the global healthcare sector. Listed on the New York Stock Exchange, the fund seeks to deliver long-term capital appreciation by investing primarily in equity securities of companies engaged in pharmaceuticals, biotechnology, medical devices, healthcare services and related industries. Managed by the global healthcare equity team at Abrdn plc, the fund leverages the firm’s deep sector expertise and research capabilities to identify innovative businesses and established market leaders in both developed and emerging markets.

The fund’s portfolio spans a broad range of healthcare subsectors, including drug developers, medical equipment manufacturers, health insurers and providers of diagnostics and digital health solutions.